Tumor markers and drug targeting

Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. Most tumor markers are made by normal cells as well as by cancer cells; however, they are produced at much higher levels in cancerous conditions. These substances can be found in the blood, urine, stool, tumor tissue, or other tissues or bodily fluids of some patients with cancer. Most tumor markers are proteins. Thus far, more than 20 different tumor markers have been characterized and are in clinical use. Some are associated with only one type of cancer, whereas others are associated with two or more cancer types. There is no “universal” tumor marker that can detect any type of cancer. Among various approaches to specifically target drug-loaded carrier systems to required pathological sites in the body, two seem to be most advanced – passive (EPR effect-mediated) targeting, based on the longevity of the pharmaceutical carrier in the blood and its accumulation in pathological sites with compromised vasculature, and active targeting, based on the attachment of specific ligands to the surface of pharmaceutical carriers to recognize and bind pathological cells. 

    Related Conference of Tumor markers and drug targeting

    June 23-24, 2020

    34th World Congress on Vaccines and Immunization

    Osaka, Japan
    June 25-26, 2020

    Global Congress on Asthma, Allergy and Immunology

    Bali, Indonesia
    October 12-13, 2020

    35th World Congress on Immunology

    London, UK
    October 12-13, 2020

    International Conference on Vaccine and Vaccine Research

    Manila, Philippines
    October 14-15, 2020

    13th International Conference on Allergy & Immunology

    Zurich, Switzerland
    October 15-16, 2020

    4th International Conference on Mass Spectrometry

    Cape Town, South Africa
    October 19-20, 2020

    2nd World Conference on Vaccine and Immunology

    Helsinki, Finland
    October 26-27, 2020

    13th Global Summit on Immunology and Cell Biology

    Amsterdam, Netherlands
    October 26-27, 2020

    10th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 28-29, 2020

    12th Annual Conference on Clinical Immunology

    Dubai, UAE
    October 29-30, 2020

    International Conference on HIV and AIDS

    Cape Town, South Africa
    November 02-03, 2020

    36th International Conference on Immunology

    Rome, Italy
    November 05-06, 2020

    4th Annual Summit on Rare Diseases and Orphan Drugs

    Paris, France
    November 18-19, 2020

    International Conference on Immunology & Immunotherapies

    Bangkok, Thailand
    December 07-08, 2020

    8th World Summit on Allergy and Clinical Immunology

    Prague, Czech Republic

    Tumor markers and drug targeting Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in